Learn more

ATHERA BIOTECHNOLOGIES AB

Overview
  • Total Patents
    90
  • GoodIP Patent Rank
    103,996
  • Filing trend
    ⇩ 100.0%
About

ATHERA BIOTECHNOLOGIES AB has a total of 90 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1999. It filed its patents most often in United States, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are INTERMUNE LIFE SCIENCES INC, BARNEA EYTAN R and PROTEINEXPRESS CO LTD.

Patent filings per year

Chart showing ATHERA BIOTECHNOLOGIES ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Frostegard Johan 35
#2 Pettersson Knut 32
#3 Camber Ola 23
#4 Sexton Dan 20
#5 De Faire Ulf 19
#6 Nixon Andrew E 18
#7 Frostegaard Johan 12
#8 Dahlbom Ingrid 8
#9 Frostegård Johan 8
#10 Pedersen Nancy 7

Latest patents

Publication Filing date Title
GB202101962D0 Methods and compositions
GB202000351D0 Methods and compositions
WO2013020995A1 New antibodies against phosphorylcholine
CA2843960A1 Antibodies binding to phosphorylcholine (pc) and/or pc conjugates
WO2012010291A1 Diagnostic and therapeutic methods and compositions for metabolic disease
WO2012010290A1 Diagnostic and therapeutic methods and compositions for metabolic disease
AU2009267417A1 New therapeutic and diagnostic methods for Alzheimer's disease
CA2715859A1 Compounds and methods for the prevention or treatment of restenosis comprising annexin a5
BRPI0821272A2 Methods for the treatment of vascular dysfunction, to reduce ischemic pain and for the treatment, prevention or reduction of risk of onset of a vascular disease, and annexin a5 or functional analogue or variant thereof
WO2009056826A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease
AU2005233361A1 Phosphorylcholine conjugates and corresponding antibodies
CN1997385A Annexin V for preventing atherothrombois and plaque rupture
US6780605B1 Method of diagnosing cardiovascular disease and early atherosclerosis